BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4032135)

  • 21. Population screening for medium-chain acyl-CoA dehydrogenase deficiency: analysis of medium-chain fatty acids and acylglycines in blood spots.
    Bennett MJ; Ragni MC; Ostfeld RJ; Santer R; Schmidt-Sommerfeld E
    Ann Clin Biochem; 1994 Jan; 31 ( Pt 1)():72-7. PubMed ID: 8154855
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medium-chain acyl-CoA dehydrogenase deficiency in two siblings with a Reye-like syndrome.
    Bougnères PF; Rocchiccioli F; Kølvraa S; Hadchouel M; Lalau-Keraly J; Chaussain JL; Wadman SK; Gregersen N
    J Pediatr; 1985 Jun; 106(6):918-21. PubMed ID: 3998948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous L-carnitine and acetyl-L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency and isovaleric acidemia.
    Van Hove JL; Kahler SG; Millington DS; Roe DS; Chace DH; Heales SJ; Roe CR
    Pediatr Res; 1994 Jan; 35(1):96-101. PubMed ID: 8134205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxidation of unsaturated fatty acids by human fibroblasts with very-long-chain acyl-CoA dehydrogenase deficiency: aspects of substrate specificity and correlation with clinical phenotype.
    Roe DS; Vianey-Saban C; Sharma S; Zabot MT; Roe CR
    Clin Chim Acta; 2001 Oct; 312(1-2):55-67. PubMed ID: 11580910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medium-chain acyl-CoA dehydrogenase deficiency in children with non-ketotic hypoglycemia and low carnitine levels.
    Stanley CA; Hale DE; Coates PM; Hall CL; Corkey BE; Yang W; Kelley RI; Gonzales EL; Williamson JR; Baker L
    Pediatr Res; 1983 Nov; 17(11):877-84. PubMed ID: 6646897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-ketotic C6-C10-dicarboxylic aciduria: biochemical investigations of two cases.
    Gregersen N; Rosleff F; Kølvraa S; Hobolth N; Rasmussen K; Lauritzen R
    Clin Chim Acta; 1980 Mar; 102(2-3):179-89. PubMed ID: 6892795
    [TBL] [Abstract][Full Text] [Related]  

  • 30. On the biologic origin of C6-C10-dicarboxylic and C6-C10-omega-1-hydroxy monocarboxylic acids in human and rat with acyl-CoA dehydrogenation deficiencies: in vitro studies on the omega- and omega-1-oxidation of medium-chain (C6-C12) fatty acids in human and rat liver.
    Gregersen N; Mortensen PB; Kølvraa S
    Pediatr Res; 1983 Oct; 17(10):828-34. PubMed ID: 6634246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary 3-hydroxydicarboxylic acids in pathophysiology of metabolic disorders with dicarboxylic aciduria.
    Tserng KY; Jin SJ; Kerr DS; Hoppel CL
    Metabolism; 1991 Jul; 40(7):676-82. PubMed ID: 1870421
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distinction of dicarboxylic aciduria due to medium-chain triglyceride feeding from that due to abnormal fatty acid oxidation and fasting in children.
    Tserng KY; Griffin RL; Kerr DS
    Metabolism; 1996 Feb; 45(2):162-7. PubMed ID: 8596483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro fibroblast studies in a patient with C6-C10-dicarboxylic aciduria: evidence for a defect in general acyl-CoA dehydrogenase.
    Kølvraa S; Gregersen N; Christensen E; Hobolth N
    Clin Chim Acta; 1982 Nov; 126(1):53-67. PubMed ID: 7172449
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic deficiency of medium-chain acyl coenzyme A dehydrogenase: studies in cultured skin fibroblasts and peripheral mononuclear leukocytes.
    Coates PM; Hale DE; Stanley CA; Corkey BE; Cortner JA
    Pediatr Res; 1985 Jul; 19(7):671-6. PubMed ID: 4022673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of carnitine and specific acylcarnitines by high-performance liquid chromatography: application to normal human urine and urine from patients with methylmalonic aciduria, isovaleric acidemia or medium-chain acyl-CoA dehydrogenase deficiency.
    Minkler PE; Hoppel CL
    J Chromatogr; 1993 Apr; 613(2):203-21. PubMed ID: 8491807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A method for quantitative acylcarnitine profiling in human skin fibroblasts using unlabelled palmitic acid: diagnosis of fatty acid oxidation disorders and differentiation between biochemical phenotypes of MCAD deficiency.
    Okun JG; Kölker S; Schulze A; Kohlmüller D; Olgemöller K; Lindner M; Hoffmann GF; Wanders RJ; Mayatepek E
    Biochim Biophys Acta; 2002 Oct; 1584(2-3):91-8. PubMed ID: 12385891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3-Hydroxydicarboxylic aciduria--a fatty acid oxidation defect with severe prognosis.
    Hagenfeldt L; von Döbeln U; Holme E; Alm J; Brandberg G; Enocksson E; Lindeberg L
    J Pediatr; 1990 Mar; 116(3):387-92. PubMed ID: 2308028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Generalized epilepsy disclosing medium-chain-acyl-CoA dehydrogenase deficiency].
    Chabrol B; Mancini J; Bertrand C; Vianey-Saban C; Divry P; Livet MO; Pinsard N
    Arch Fr Pediatr; 1993; 50(6):497-500. PubMed ID: 8135611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of abnormal urinary metabolites in the newborn period in medium-chain acyl-CoA dehydrogenase deficiency.
    Bennett MJ; Coates PM; Hale DE; Millington DS; Pollitt RJ; Rinaldo P; Roe CR; Tanaka K
    J Inherit Metab Dis; 1990; 13(5):707-15. PubMed ID: 2246856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The measurement of carnitine and acyl-carnitines: application to the investigation of patients with suspected inherited disorders of mitochondrial fatty acid oxidation.
    Bhuiyan AK; Jackson S; Turnbull DM; Aynsley-Green A; Leonard JV; Bartlett K
    Clin Chim Acta; 1992 May; 207(3):185-204. PubMed ID: 1327583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.